PT-141 (Bremelanotide)

PT-141 (bremelanotide) is an FDA-approved active (Vyleesi). Prescription-only, physician-reviewed.

How it works

PT-141 (bremelanotide) is a melanocortin-receptor agonist, and it's a genuinely different kind of molecule from the familiar ED pills. PDE5 inhibitors like sildenafil work on blood flow in the periphery. PT-141 works centrally — it activates melanocortin receptors (notably MC4R) in the brain, on pathways involved in sexual desire and arousal rather than on the plumbing.

It is an FDA-approved active (marketed as Vyleesi, approved for hypoactive sexual desire disorder in premenopausal women) and was studied in randomized, placebo-controlled phase-3 trials. That central, desire-oriented mechanism is what distinguishes it, and it's also why its side-effect profile — nausea, flushing, transient blood-pressure changes — looks different from the blood-flow drugs.

What it's been studied for

• —Sexual desire, in randomized placebo-controlled phase-3 trials (RECONNECT)
• —Central (brain-mediated) rather than vascular pathways for sexual response

“Studied for” describes what research has examined — not a promise of any outcome for you.

What the evidence says

Bremelanotide is an FDA-approved active studied in randomized phase-3 trials (RECONNECT). Source: Kingsberg et al. (RECONNECT), Obstet Gynecol 2019.

What to expect at Clyne

Because bremelanotide is an FDA-approved active, it's prescribed under standard prescription rules after a provider reviews your intake. Baseline labs aren't typically required, though your provider may want to know your blood-pressure and cardiovascular history.

Your provider sets the specifics for your prescription and explains what to expect, including the timing of how it's used and the side effects that are common versus ones that warrant a call.

Safety & considerations

PT-141 isn't for everyone. Your provider screens for uncontrolled high blood pressure and cardiovascular disease, among other factors, because transient blood-pressure increases and heart-rate changes are documented effects. Nausea is the most commonly reported side effect in trials, and some people notice darkening of the skin with repeated use.

Tell your provider about all medications, especially anything for blood pressure. This is a case where the FDA approval gives a clearer evidence base than most peptides — but 'approved' still doesn't mean 'right for everyone.'

Regulatory status

This is an FDA-approved active medication, prescribed under standard prescription rules. A regulatory category that permits compounding is not the same as FDA approval.

Common questions